SCHEMBL27853

SCHEMBL27853

O=C1c2cc(-c3cc(F)cc(Cl)c3)ccc2OC12CCC1=CCCC=C1CC2

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PGR P06401 5/20 0.39
BACE1 P56817 12/20 0.38
CTSD P07339 4/20 0.38
CTSB P07858 2/20 0.33
MAP4K4 O95819 1/20 0.33
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
MAPT P10636 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1465053 0.86 BACE1 (0.48) PGRBACE1CTSDCTSBMAP4K4
SCHEMBL27852 0.82 PGR (0.36) PGRBACE1CTSDCTSB
SCHEMBL28188 0.74 HDAC3 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL12746141 0.71 BACE1 (0.47) PGRBACE1CTSDCTSBMAP4K4
SCHEMBL1464483 0.68 BACE1 (0.44) PGRBACE1CTSDCTSBMAP4K4
SCHEMBL1464484 0.68 BACE1 (0.44) PGRBACE1CTSDCTSBMAP4K4
SCHEMBL28509648 0.62 HDAC3 (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1465164 0.60 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23561634 0.58 HDAC3 (0.45) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL562565 0.58 CA1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406240-A2 INHIBITORS OF BETA-SECRETASE Vitae Pharmaceuticals, Inc. (US) 2012-01-18 EP disclosed
WO-2010105179-A2 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. (US) 2010-09-16 WO disclosed